{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:49:24Z","timestamp":1760042964727},"reference-count":18,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1713,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1365-2893.2010.01412.x","type":"journal-article","created":{"date-parts":[[2010,12,29]],"date-time":"2010-12-29T10:17:26Z","timestamp":1293617846000},"page":"892-896","source":"Crossref","is-referenced-by-count":34,"title":["Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine"],"prefix":"10.1111","volume":"18","author":[{"given":"X. J.","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Q.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Y.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,23]]},"reference":[{"issue":"2","key":"10.1111\/j.1365-2893.2010.01412.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"Liaw","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1111\/j.1365-2893.2010.01412.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1590-8658(02)80136-0","article-title":"Lamivudine-induced muscle mitochondrial toxicity","volume":"34","author":"Ojetti","year":"2002","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1111\/j.1365-2893.2010.01412.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.22959","article-title":"Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA","volume":"49","author":"Seok","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1111\/j.1365-2893.2010.01412.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jhep.2009.06.011","article-title":"Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B","volume":"51","author":"Fleischer","year":"2009","journal-title":"J Hepatol"},{"issue":"3","key":"10.1111\/j.1365-2893.2010.01412.x-BIB5|cit5","first-page":"201","article-title":"An unusual reaction to telbivudine: rhabdomyolysis","volume":"11","author":"Liu","year":"2009","journal-title":"Yao Wu Bu Liang Fan Ying Za Zhi"},{"issue":"22","key":"10.1111\/j.1365-2893.2010.01412.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.3748\/wjg.14.3549","article-title":"Clinical features of adverse reactions associated with telbivudine","volume":"14","author":"Zhang","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1111\/j.1365-2893.2010.01412.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","author":"European Association For The Study Of The Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01412.x-BIB8|cit8","unstructured":"Avila C Laeufle R Bao W CK elevation during chronic hepatitis B (CHB)treatment with telbivudine: experience from the combined GLOBE f NV-02B-007\/CLDT600A2302) and NV-02B-015(015) study clinical safety database: Poster#PE 140 2009"},{"issue":"9","key":"10.1111\/j.1365-2893.2010.01412.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.str.0000034125.94759.41","article-title":"ACC\/AHA\/NHLBI Clinical Advisory on the Use and Safety of Statins","volume":"33","author":"Pasternak","year":"2002","journal-title":"Stroke"},{"issue":"25","key":"10.1111\/j.1365-2893.2010.01412.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1111\/j.1365-2893.2010.01412.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/vim.2010.0042","article-title":"Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines","volume":"23","author":"Wu","year":"2010","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1111\/j.1365-2893.2010.01412.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1152\/japplphysiol.00085.2007","article-title":"Exercise, MAPK, and NF-kappaB signaling in skeletal muscle","volume":"103","author":"Kramer","year":"2007","journal-title":"J Appl Physiol"},{"issue":"Suppl 1","key":"10.1111\/j.1365-2893.2010.01412.x-BIB13|cit13","first-page":"655","article-title":"Creatine kinase elevations and muscle toxicities associated with chronic telbivudine use in prospective clinical trials","volume":"46","author":"Brown","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"10.1111\/j.1365-2893.2010.01412.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.clinthera.2007.12.032","article-title":"Telbivudine for the management of chronic hepatitis B virus infection","volume":"29","author":"Matthews","year":"2007","journal-title":"Clin Ther"},{"issue":"2","key":"10.1111\/j.1365-2893.2010.01412.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/toxsci\/kfh208","article-title":"Mitochondrial damage revealed by morphometric and semiquantitative analysis of mouse pup cardiomyocytes following in utero and postnatal exposure to zidovudine and lamivudine","volume":"81","author":"Bishop","year":"2004","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1111\/j.1365-2893.2010.01412.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1345\/aph.1G027","article-title":"Telbivudine: a novel nucleoside analog for chronic hepatitis B","volume":"40","author":"Kim","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1111\/j.1365-2893.2010.01412.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1258\/095646205774988127","article-title":"Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: potential benefit of coenzyme Q10 therapy","volume":"16","author":"Rosenfeldt","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"7","key":"10.1111\/j.1365-2893.2010.01412.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3949\/ccjm.77a.09078","article-title":"Coenzyme Q10: a therapy for hypertension and statin-induced myalgia","volume":"77","author":"Wyman","year":"2010","journal-title":"Cleve Clin J Med"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2010.01412.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2010.01412.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T08:42:53Z","timestamp":1625560973000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2010.01412.x"}},"subtitle":["CK elevations and myopathy with telbivudine"],"short-title":[],"issued":{"date-parts":[[2010,12,23]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01412.x","relation":{},"ISSN":["1352-0504"],"issn-type":[{"value":"1352-0504","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,23]]}}}